Apple plan to revolutionize mobile healthcare: Personalized medicine at the horizon on the iPhone and the likes

Last Updated on

Apple has unveiled HealthKit, a platform to centralise data from different types of devices, like fitness trackers, heart rate and blood pressure monitors.

iphone healthLaunching iOS 8 for iPhones and iPads, which it describes as the biggest release since the launch of the App Store, Apple gave much prominence to HealthKit, which “gathers the information you choose from your various health apps and fitness devices, and provides you with a clear and current overview in one place”. The new operating system offers developers the ability for these apps “to communicate with each other”, the company said, and with permission of the user, each app can use specific information from other apps “to provide a more comprehensive way to manage your health and fitness”.

Apple gave the example of the Nike+ apps using NikeFuel which “will be able to pull in other key HealthKit metrics such as sleep and nutrition to build a custom user profile”. It has also teamed up with Mayo Clinic in a move which will see the world-famous medical group launch a new app in September offering its patients and consumers easy-access personalised health information, guidance and care when they need it. Mayo chief executive John Noseworthy said that “we believe Apple’s HealthKit will revolutionize how the health industry interacts with people”. Apple is also collaborating with the electronic health records major Epic Systems so that HealthKit can be used by healthcare professionals to monitor specific patient data. Craig Federighi, Apple’s head of software engineering, said the scheme is giving developers “amazing new tools” to make managing health from devices “an integrated, simple and secure experience”.

Such technologies may help to make one day personalized medicine truly personal. Individuals may compare vital data, collected from  themselves  via devices such as,  let’s say, iWatches and other wearables, with their resulting phenotype (i.e., diabetic, obese, anemic, etc.). Based on their own personal genetic background related to these phenotypes, individuals may decide on measures to take on a personal basis (for example, talk to friends about her/his condition in social networks, request more information about her/his condition from intelligent online knowledge sytems, see the doctor, etc.). All at her/his pace, and at her/his level of trust, comfort, and privacy. Perhaps, she/he feels like sharing her/his experience, fears, questions, and successes with the community. That’s what social networks in health and disease could be all about.

Tags: , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login

Notify of

[…] device technologies in the individualized monitoring of vital factors (e.g., glucose) and/or in theragenomic and personalised medicine in […]

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Genes, the social environment, and adolescent smoking September 17, 2019
    Adolescence is a time of dramatic change. It marks a period of significant physical transformation—such as the drive toward sexual maturity. But it can also be a time of considerable psychological change and social experimentation.
  • Cause of rare, fatal disorder in young children pinpointed September 17, 2019
    Scientists at Washington University School of Medicine in St. Louis appear to have solved a decades-long mystery regarding the precise biochemical pathway leading to a fatal genetic disorder in children that results in seizures, developmental regression and death, usually around age 3. Studying a mouse model with the same human illness—called Krabbe disease—the researchers also […]
  • Gene-targeted cancer drugs, slow release overcome resistance September 16, 2019
    Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and biomaterials science to improve the efficacy, accuracy and longevity of certain cancer therapies.
  • Genetic mutation appears to protect some people from deadly MRSA September 16, 2019
    An inherited genetic tendency appears to increase the likelihood that a person can successfully fight off antibiotic-resistant staph infections, according to a study led by Duke Health researchers.
  • Renegade genes caught red handed September 16, 2019
    The guardians of the human genome that work to prevent potentially disease-causing gene expression might not be as effective at their jobs as previously thought, according to new University of Arizona research.